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To gain a better insight into the initiation and regulation of this process during development, we are performing a detailed spatial and temporal transcriptional analysis of cardiac crescent development using single-cell RNAseq (scRNA-seq). We have sequenced over 2000 single cells from left and right portions of the cardiac crescent separately, spanning four stages of cardiac crescent maturation prior to the formation of the linear heart tube. Using bioinformatic analyses we identified several candidate genes potentially responsible for the processes mentioned above. Complimentary Calcium imaging of chick embryonic hearts revealed a different dynamic in terms of the left-right propagation of the calcium transients and the timing of the first heartbeats. We therefore performed qRT-PCR on chick and mouse embryonic hearts in order to identify the pathways likely to be responsible for the mouse specific physiological behaviors we have observed. I will present an overview of the genetic regulatory networks involved in the developmental physiology of the embryonic heart. Morphogens determine cell fate in a concentration dependent manner. Developing tissues are often dynamic and it is unclear how morphogens reliably determine cell fate in such contexts. We address this problem using as a model the specification of muscle fibre types by the morphogens Shh, BMP and FGF in the zebrafish embryo. FGF reportedly determines the allocation of slow-twitch fibre progenitors to the Muscle Pioneer (MP) fate as a function of position along the anterior-posterior axis, yet by cell tracking, we find no anterior-posterior bias in their induction. Nevertheless, inhibition of the FGF pathway does increase MP number. FGF pathway inhibition delays fast-twitch muscle fibre elongation and extrusion, which we show subsequently hinders migration of slowtwitch progenitors away from MPs. This delay results in increased MP number, likely due to prolonged Shh exposure. Thus, FGF nonautonomously determines MP cell fate through regulating the precise temporal migration of different cell types. pathway, activates downstream signal transduction directly through small G α protein is still in dispute. Interestingly, several new orphan GPCRs, including Gpr161, have been identified as regulators of Hedgehog signaling pathway, however, through different G α proteins. These studies raise the questions that which G α plays major role, and how these G α protein with different effects work together in Hh signal transduction? To address these questions, CRISPRCas9 DNA editing tool will be employed to generate null mutant of different G α proteins in both zebrafish and mouse tissue culture. Intensively genetic, biochemical and cellular analyses will be performed to assay the Hh signaling pathway activity in all single mutants and possible double mutants to dissect G α protein function in regulating Hh activity. In addition, in order to effectively examine the correlation between PKA activity and Hh pathway activity, stable cell lines and transgenic zebrafish carrying primary cilium (PC) compartment PKA activity reporter construct will be generated by combining the nephronophthisis 3 N terminal and PKA reporter substrate AKAR2. Using these transgenic lines, molecular mechanism of the Hh pathway will be substantially examined. These works will provide: 1) important evidence for understanding of the mechanism of Hh signal transduction; 2) new clues for identification of potential GPCRs involved in Hh pathway in different tissues and cells. Adult hippocampal neural stem cells (AH-NSCs) predominantly exist as non-proliferative quiescent neural progenitors that transition into a proliferative state during neurogenesis. It is important to understand the molecular regulation of activation of AH-NSCs to target them for neurodegenerative medicine and therapeutic intervention in brain tumor cancer stem cells. In the present study, we have taken an omics approach to understand the molecular regulation of cellular translation or ribosome biogenesis and cell cycle in stem cells from the perspective of transcription. Work from our lab and others have identified several key transcription factors (REST, ASCL1, OLIG2, SOX family, MAX, TCF3 and NFI), and their binding sites in AH-NSCs using chromatin immunoprecipitation (ChIP)-sequencing. RNA-seq analysis of gene expression showed that cell cycle and ribosome biogenesis are major gene ontologies upregulated in activated AH-NSCs. Here we combined ChIP-seq and RNA-seq omics approaches to identify distinct subset of genes within ribosome biogenesis and cell cycle genes, regulated by distinct transcription factors in activated AH-NSCs. Moreover, we functionally validated several cell cycle and ribosome biogenesis genes to show that they are sufficient, alone and in synergy to induce proliferation in AH-NSCs. Here we have shown the utility of mining DNA binding and transcriptomics data to gain a comprehensive view of regulation of AH-NSCs. Furthermore, we have established a regulatory link between cellular transcription and translation, through transcription factor mediated gene expression regulation of translation factors. This approach can identify candidate genes for drug development that hit both the transcriptional and translational hot-spots dysregulated in diseases. Supported by NIH grants R01AG032383, R21MH094715, and K02AG041815 and Welch Foundation I-1660. doi:10.1016/j.mod.2017.04.458 Abstracts S160
